Initiator Pharma A/S's total liabilities is $12M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total liabilities for INIT.ST is $12M as of June 2026. That compares with $5.5M in the prior-year period — up 125.3% year over year. Investors often review this figure alongside Initiator Pharma A/S's historical trend and sector peers before judging valuation or financial health.
Over the past year, INIT.ST's total liabilities moved from $5.5M to $12M — a 125.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Initiator Pharma A/S's operating scale or balance-sheet position.
A total liabilities figure of $12M for INIT.ST is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting INIT.ST's total liabilities ($12M), review year-over-year change from $5.5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Initiator Pharma A/S's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.